taxonomy (1)
protein (1)
source (3)
structure (30)
composition (42)
disease (2)
reference (6)
site (4)
peptide (3)
- Homo sapiens (Human)
Taxonomy
- Protein YIPF3 / Homo sapiens Q9GZM5
Protein
- Mammary Gland (UBERON_0001911)
- Urine (UBERON_0001088)
- Cerebrospinal Fluid Secretion (GO_0033326)
Source
- O-Linked / Core 1 / Structure 9458
- O-Linked / Core 1 / Structure 9323
- O-Linked / Core 1 / Structure 9311
- O-Linked / Core 1 / Structure 9242
- O-Linked / Core 1 / Structure 9345
- O-Linked / Core 1 / Structure 9295
- O-Linked / Core 1 / Structure 9335
- O-Linked / Core 2 / Structure 9504
- O-Linked / Core 2 / Structure 9519
- O-Linked / Core 2 / Structure 9322
- O-Linked / Core 2 / Structure 9351
- O-Linked / Core 2 / Structure 9359
- O-Linked / Core 2 / Structure 9432
- O-Linked / Core 2 / Structure 9518
- O-Linked / Core 2 / Structure 9435
- O-Linked / Core 2 / Structure 9253
- O-Linked / Core 2 / Structure 9366
- O-Linked / Core 2 / Structure 9361
- O-Linked / Core 2 / Structure 9365
- O-Linked / Core 2 / Structure 9530
- O-Linked / Core 2 / Structure 9360
- O-Linked / Core 2 / Structure 9383
- O-Linked / Core 2 / Structure 9382
- O-Linked / Core 2 / Structure 9387
- O-Linked / Core 2 / Structure 9391
- O-Linked / Core 2 / Structure 9363
- O-Linked / Core 2 / Structure 9436
- O-Linked / Core 2 / Structure 9543
- O-Linked / Core 2 / Structure 9369
- O-Linked / Core 2 / Structure 9479
Reported structure
- HexNAc:1 (avg mass : 221.2103 )
- Hex:1 HexNAc:1 (avg mass : 383.3527 )
- Hex:1 HexNAc:1 NeuAc:1 (avg mass : 674.6106 )
- Hex:1 HexNAc:1 NeuAc:1 Ac:1 (avg mass : 716.6473 )
- Hex:1 HexNAc:1 NeuAc:1 NeuGc:1 (avg mass : 981.8679 )
- Hex:1 HexNAc:1 NeuAc:2 (avg mass : 965.8685 )
- Hex:1 HexNAc:1 NeuAc:2 Ac:1 (avg mass : 1007.9052 )
- Hex:1 HexNAc:1 NeuAc:2 Ac:2 (avg mass : 1049.9419 )
- Hex:1 HexNAc:1 NeuAc:3 (avg mass : 1257.1264 )
- Hex:1 HexNAc:1 NeuAc:3 Ac:1 (avg mass : 1299.1631 )
- Hex:1 HexNAc:1 NeuAc:3 Ac:2 (avg mass : 1341.1998 )
- Hex:1 HexNAc:1 NeuAc:3 Ac:3 (avg mass : 1383.2365 )
- Hex:1 HexNAc:2 (avg mass : 586.5477 )
- Hex:2 HexNAc:2 (avg mass : 748.6901 )
- Hex:2 HexNAc:2 NeuAc:2 (avg mass : 1331.2059 )
- Hex:2 HexNAc:2 NeuAc:2 Ac:1 (avg mass : 1373.2426 )
- Hex:2 HexNAc:2 NeuAc:2 Ac:2 (avg mass : 1415.2793 )
- Hex:2 HexNAc:2 NeuAc:2 Su:1 (avg mass : 1411.2701 )
- Hex:2 HexNAc:2 NeuAc:3 Ac:1 (avg mass : 1664.5005 )
- Hex:2 HexNAc:2 NeuAc:3 Ac:2 (avg mass : 1706.5372 )
- Hex:2 HexNAc:2 dHex:1 (avg mass : 894.8331 )
- Hex:2 HexNAc:2 dHex:1 NeuAc:1 (avg mass : 1186.091 )
- Hex:2 HexNAc:2 dHex:1 NeuAc:2 (avg mass : 1477.3489 )
- Hex:2 HexNAc:2 dHex:1 NeuAc:2 Ac:1 (avg mass : 1519.3856 )
- Hex:2 HexNAc:2 dHex:1 NeuAc:2 Ac:2 (avg mass : 1561.4223 )
- Hex:2 HexNAc:3 NeuAc:1 (avg mass : 1243.143 )
- Hex:2 HexNAc:3 NeuAc:2 (avg mass : 1534.4009 )
- Hex:2 HexNAc:3 dHex:1 NeuAc:1 (avg mass : 1389.286 )
- Hex:3 HexNAc:3 NeuAc:2 (avg mass : 1696.5433 )
- Hex:3 HexNAc:3 dHex:1 NeuAc:2 (avg mass : 1842.6863 )
- Hex:3 HexNAc:3 dHex:2 NeuAc:2 (avg mass : 1988.8293 )
- Hex:3 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 1754.6234 )
- Hex:4 HexNAc:4 NeuAc:2 (avg mass : 2061.8807 )
- Hex:4 HexNAc:4 NeuAc:3 (avg mass : 2353.1386 )
- Hex:4 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2411.2187 )
- Hex:6 HexNAc:4 NeuAc:1 (avg mass : 2094.9076 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 NeuGc:1 (avg mass : 3042.7608 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 (avg mass : 3026.7614 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:3 (avg mass : 3392.0988 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:4 (avg mass : 3683.3567 )
- Hex:7 HexNAc:7 dHex:1 NeuAc:2 NeuGc:1 (avg mass : 3611.2932 )
- Hex:8 HexNAc:7 dHex:1 NeuAc:1 NeuGc:1 (avg mass : 3482.1777 )
Composition
- Novel O-linked sialoglycan structures in human urinary glycoproteins (2020 - Adam Pap, Ervin Tasnadi, Katalin F. Medzihradszky, Zsuzsanna Darula ) / Status : Reviewed
- Extended Sialylated O-Glycan Repertoire of Human Urinary Glycoproteins Discovered and Characterized Using Electron-Transfer/Higher-Energy Collision Dissociation (2019 - Zsuzsanna Darula, Ádám Pap, Katalin F. Medzihradszky) / Status : Reviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- LC-MS/MS characterization of O-glycosylation sites and glycan structures of human cerebrospinal fluid glycoproteins (2013 - Halim A, Rüetschi U, Larson G, Nilsson J) / Status : Reviewed
- Human urinary glycoproteomics; attachment site specific analysis of N- and O-linked glycosylations by CID and ECD (2012 - Halim A, Nilsson J, Rüetschi U, Hesse C, Larson G) / Status : Reviewed
Reference
- Protein YIPF3 / Homo sapiens
Reported glycosite
-
- O-Linked / Core 1
(avg mass : 716.6473)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- O-Linked / Core 1
(avg mass : 1007.9052)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- O-Linked / Core 1
(avg mass : 1049.9419)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- O-Linked / Core 1
(avg mass : 1257.1264)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- O-Linked / Core 1
(avg mass : 1299.1631)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- O-Linked / Core 1
(avg mass : 1341.1998)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- O-Linked / Core 1
(avg mass : 1383.2365)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- O-Linked / Core 2
(avg mass : 1186.091)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- O-Linked / Core 2
(avg mass : 1243.143)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- O-Linked / Core 2
(avg mass : 1373.2426)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- O-Linked / Core 2
(avg mass : 1373.2426)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- O-Linked / Core 2
(avg mass : 1389.286)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- O-Linked / Core 2
(avg mass : 1389.286)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- O-Linked / Core 2
(avg mass : 1389.286)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- O-Linked / Core 2
(avg mass : 1411.2701)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- O-Linked / Core 2
(avg mass : 1415.2793)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- O-Linked / Core 2
(avg mass : 1477.3489)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
- Protein YIPF3 / Homo sapiens
-
- O-Linked / Core 2
(avg mass : 1519.3856)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- O-Linked / Core 2
(avg mass : 1519.3856)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- O-Linked / Core 2
(avg mass : 1534.4009)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- O-Linked / Core 2
(avg mass : 1561.4223)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- O-Linked / Core 2
(avg mass : 1664.5005)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- O-Linked / Core 2
(avg mass : 1696.5433)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- O-Linked / Core 2
(avg mass : 1706.5372)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- O-Linked / Core 2
(avg mass : 1754.6234)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- O-Linked / Core 2
(avg mass : 1842.6863)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- O-Linked / Core 2
(avg mass : 1988.8293)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- O-Linked / Core 2
(avg mass : 2061.8807)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- O-Linked / Core 2
(avg mass : 2353.1386)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- O-Linked / Core 2
(avg mass : 2411.2187)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- Hex:6 HexNAc:4 NeuAc:1 / N-Linked
(avg mass : 2094.9076)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Protein YIPF3 / Homo sapiens
- LNATAK (6aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 / N-Linked
(avg mass : 3026.7614)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Protein YIPF3 / Homo sapiens
- LPTTVLNATAK (11aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 NeuGc:1 / N-Linked
(avg mass : 3042.7608)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Protein YIPF3 / Homo sapiens
- LPTTVLNATAK (11aa)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:3 / N-Linked
(avg mass : 3392.0988)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Protein YIPF3 / Homo sapiens
- LPTTVLNATAK (11aa)
-
- Hex:8 HexNAc:7 dHex:1 NeuAc:1 NeuGc:1 / N-Linked
(avg mass : 3482.1777)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Protein YIPF3 / Homo sapiens
- LPTTVLNATAK (11aa)
-
- Hex:7 HexNAc:7 dHex:1 NeuAc:2 NeuGc:1 / N-Linked
(avg mass : 3611.2932)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Protein YIPF3 / Homo sapiens
- LPTTVLNATAK (11aa)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:4 / N-Linked
(avg mass : 3683.3567)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Protein YIPF3 / Homo sapiens
- LPTTVLNATAK (11aa)
-
- Hex:1 HexNAc:2 / O-Linked
(avg mass : 586.5477)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
-
- HexNAc:1 / O-Linked
(avg mass : 221.2103)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
-
- Hex:1 HexNAc:1 / O-Linked
(avg mass : 383.3527)
- LC-MS/MS characterization of O-glycosylation sites and glycan structures of human cerebrospinal fluid glycoproteins (2013 - Halim A, Rüetschi U, Larson G, Nilsson J) / Status : Reviewed
- Human urinary glycoproteomics; attachment site specific analysis of N- and O-linked glycosylations by CID and ECD (2012 - Halim A, Nilsson J, Rüetschi U, Hesse C, Larson G) / Status : Reviewed
- Protein YIPF3 / Homo sapiens
-
- Hex:1 HexNAc:1 NeuAc:1 / O-Linked
(avg mass : 674.6106)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- Hex:2 HexNAc:2 / O-Linked
(avg mass : 748.6901)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
-
- Hex:2 HexNAc:2 dHex:1 / O-Linked
(avg mass : 894.8331)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
-
- Hex:1 HexNAc:1 NeuAc:2 / O-Linked
(avg mass : 965.8685)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- Hex:1 HexNAc:1 NeuAc:1 NeuGc:1 / O-Linked
(avg mass : 981.8679)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- Hex:2 HexNAc:2 NeuAc:2 / O-Linked
(avg mass : 1331.2059)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- Hex:2 HexNAc:2 dHex:1 NeuAc:2 / O-Linked
(avg mass : 1477.3489)
- Urine (UBERON_0001088)
- O-Linked / Core 2 / Structure 9366
- Prostate cancer (DOID:10283)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:2 HexNAc:2 dHex:1 NeuAc:2 / O-Linked
(avg mass : 1477.3489)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:2 HexNAc:2 NeuAc:2 / O-Linked
(avg mass : 1331.2059)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:1 HexNAc:1 NeuAc:1 NeuGc:1 / O-Linked
(avg mass : 981.8679)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:1 HexNAc:1 NeuAc:2 / O-Linked
(avg mass : 965.8685)
Source
Suggested structure
Reported glycosite
- Hex:2 HexNAc:2 dHex:1 / O-Linked
(avg mass : 894.8331)
Source
Suggested structure
Reported glycosite
- Hex:2 HexNAc:2 / O-Linked
(avg mass : 748.6901)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:1 HexNAc:1 NeuAc:1 / O-Linked
(avg mass : 674.6106)
Suggested structure
Reference
Reported glycosite
- Hex:1 HexNAc:1 / O-Linked
(avg mass : 383.3527)
Source
Suggested structure
Reported glycosite
- HexNAc:1 / O-Linked
(avg mass : 221.2103)
Source
Suggested structure
Reported glycosite
- Hex:1 HexNAc:2 / O-Linked
(avg mass : 586.5477)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:7 HexNAc:6 dHex:1 NeuAc:4 / N-Linked
(avg mass : 3683.3567)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:7 HexNAc:7 dHex:1 NeuAc:2 NeuGc:1 / N-Linked
(avg mass : 3611.2932)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:8 HexNAc:7 dHex:1 NeuAc:1 NeuGc:1 / N-Linked
(avg mass : 3482.1777)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:7 HexNAc:6 dHex:1 NeuAc:3 / N-Linked
(avg mass : 3392.0988)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 NeuGc:1 / N-Linked
(avg mass : 3042.7608)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 / N-Linked
(avg mass : 3026.7614)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:4 NeuAc:1 / N-Linked
(avg mass : 2094.9076)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- O-Linked / Core 2
(avg mass : 2411.2187)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- O-Linked / Core 2
(avg mass : 2353.1386)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- O-Linked / Core 2
(avg mass : 2061.8807)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- O-Linked / Core 2
(avg mass : 1988.8293)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- O-Linked / Core 2
(avg mass : 1842.6863)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- O-Linked / Core 2
(avg mass : 1754.6234)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- O-Linked / Core 2
(avg mass : 1706.5372)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- O-Linked / Core 2
(avg mass : 1696.5433)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- O-Linked / Core 2
(avg mass : 1664.5005)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- O-Linked / Core 2
(avg mass : 1561.4223)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- O-Linked / Core 2
(avg mass : 1534.4009)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- O-Linked / Core 2
(avg mass : 1519.3856)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- O-Linked / Core 2
(avg mass : 1519.3856)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- O-Linked / Core 2
(avg mass : 1477.3489)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- O-Linked / Core 2
(avg mass : 1415.2793)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- O-Linked / Core 2
(avg mass : 1411.2701)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- O-Linked / Core 2
(avg mass : 1389.286)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- O-Linked / Core 2
(avg mass : 1389.286)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- O-Linked / Core 2
(avg mass : 1389.286)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- O-Linked / Core 2
(avg mass : 1373.2426)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- O-Linked / Core 2
(avg mass : 1373.2426)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- O-Linked / Core 2
(avg mass : 1243.143)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- O-Linked / Core 2
(avg mass : 1186.091)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- O-Linked / Core 1
(avg mass : 1383.2365)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- O-Linked / Core 1
(avg mass : 1341.1998)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- O-Linked / Core 1
(avg mass : 1299.1631)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- O-Linked / Core 1
(avg mass : 1257.1264)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- O-Linked / Core 1
(avg mass : 1049.9419)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- O-Linked / Core 1
(avg mass : 1007.9052)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- O-Linked / Core 1
(avg mass : 716.6473)
